Zolpidem Tartrate
Product Images NDC 0093-0074

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 0093-0074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure diagram showing the molecular structure of zolpidem tartrate, with separate structural representations of zolpidem and tartaric acid components.*

FDA Label Image

Image 2

Label for Zolpidem Tartrate Tablets USP 5 mg by Teva Pharmaceuticals USA, Inc., indicating the product is Schedule IV. The label includes instructions to dispense the accompanying medication guide and lists the package size as 100 tablets. It also displays storage instructions and a serialization coding area.*

FDA Label Image

Image 3

Label for Zolpidem Tartrate Tablets, USP 10 mg by Teva Pharmaceuticals USA, Inc. It displays the product name, strength (10 mg), dosage form as tablets, and contains 100 tablets per package. The label includes a barcode, storage instructions, child safety warnings, and a notice to dispense the medication guide to each patient. Marked as Rx only with a red 10 mg strength indicator and the Teva logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.